Healthcare >> Analyst Interviews >> August 11, 2000

European Pharmaceutical Stocks

Nigel Barnes is a Senior Pharmaceutical Analyst with Merrill Lynch. Profile
TWST: The pharmaceuticals have been on the rise since their peak in March. What do you see to be the major factors that played into that performance?



Mr. Barnes: I think generally